000			03712nam a22005175i 4500
001			978-3-319-28368-5
003			DE-He213
005			20160615101133.0
007			cr nn 008mamaa
008			160324s2016 gw | s |||| 0|eng d
020			_a9783319283685 _9978-3-319-28368-5
024	7		_a10.1007/978-3-319-28368-5 _2doi
049			_aAlfaisal Main Library
050		4	_aQR1-502
072		7	_aPSG _2bicssc
072		7	_aSCI045000 _2bisacsh
082	0	4	_a579 _223
245	1	0	_aNew Weapons to Control Bacterial Growth _h[electronic resource] / _cedited by Tomas G. Villa, Miguel Vinas.
250			_a1st ed. 2016.
264		1	_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2016.
300			_aVI, 556 p. 78 illus., 60 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_aBacteriocins -- Control of bacterial growth through RNA degradation -- Control of Pathogenic Clostridia -- DNA-synthesizing enzymes as antibacterial targets -- Inhibition of bacterial efflux pump activity as a way to control microbial growth -- Bacterial protease as targets to control bacterial growth -- Quorum sensing and competence stimulation as targets for antimicrobial chemotherapy -- Transcriptomics as a tool to finding new antibacterial targets -- The case of Lipid II: the Achille´s heel of bacteria -- Microbiome Control in the Prevention and Early Management of Cancer -- Targets against Helicobacter pylori and other tumor-producing bacteria -- Intestinal Microbiota: First barrier against gut-affecting pathogens -- Fecal matter implantation as a way to fight diarrhea-causing microorganisms -- Different approaches for searching new microbial antibiotics controlling bacterial growth -- Synthetic peptides as antimicrobials -- The use of nanoparticles for antimicrobials delivery -- Predation and competition: bacteriophages and bacteria as antimicrobial agents.
520			_aWritten by specialists in the different fields, this book presents new perspectives and insights into strategies and weapons to fight microbial infections. It also reviews the “state of the art” of alternative treatment approaches and new therapeutic agents to deal with infections caused by multidrug-resistant microorganisms. In an era of accumulated resistance to current antibiotics, it is vital that this is undertaken without further delay. Aspects discussed include the control of RNA synthesis, the use of bacteriocins or enzybiotics (bacteriophages or purified lysins), the specific control of pathogenic clostridia, the design of new drugs affecting DNA synthesis in bacteria, the use of fecal-matter transplant strategies, the specific control of quorum sensing responses in bacteria, the use of new peptides as antibiotics and new ways to control bacteria that cause cancer, such as Helicobacter pylori cancers.
650		0	_aLife sciences.
650		0	_aMedical microbiology.
650		0	_aInfectious diseases.
650		0	_aMicrobiology.
650	1	4	_aLife Sciences.
650	2	4	_aMicrobiology.
650	2	4	_aMedical Microbiology.
650	2	4	_aInfectious Diseases.
655		7	_aElectronic books. _2local
700	1		_aVilla, Tomas G. _eeditor.
700	1		_aVinas, Miguel. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783319283661
856	4	0	_uhttp://ezproxy.alfaisal.edu/login?url=http://dx.doi.org/10.1007/978-3-319-28368-5
912			_aZDB-2-SBL
942			_2lcc _cEBOOKS
999			_c259308 _d259308